IgA Nephropathy: Clinical significance of urinary proteins/polypeptides characterization

Current Proteomics

Volumn 6, Issue 3, 2009, Pages 179-186

  Bazzi, Claudio ^a  

^a Fondazione D'Amico per la Ricerca sulle Malattie Renali   (Italy)

Author keywords

IgA nephropathy; Outcome; Proteinuria characterization; Therapy responsiveness; Urine proteomics

Indexed keywords

EID: 70349423766     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016409789351905     Document Type: Article

References (33)

1. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin. Nephrol., 2004, 24, 179-196.
2. Barrat, J. and Feehally, J. IgA Nephropathy. J. Am. Soc. Nephrol., 2005, 16, 2088-2097.
3. Maxwell, P.H. and Wang, Y. Genetic studies in IgA nephropathy. Nephron. Exp. Nephrol., 2006, 102, e76-e80.
4. Lee, H.S.; Choi, Y.; Lee, J.S.; Yu, B.H. and Koh, H.I. Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data. Kidney Int., 1989, 35, 880-886.
5. Coppo, R. and D'Amico, G. Factors predicting progression in IgA nephropathy. J. Nephrol., 2005, 18, 503-512.
6. Glassock, R.J. IgA nephropathy: Challenges and opportunities. Cleve. Clin. J. Med., 2008, 75, 569-576.
7. D'Amico, G. and Bazzi, C. Pathophysiology of proteinuria. Kidney Int., 2003, 63, 809-825.
8. Barrat, J. and Feehally, J. Treatment of IgA nephropathy. Kidney Int., 2006, 69, 1934-1938.
9. Tumlin, J.A.; Lohavichan, V. and Hennigar, R. Crescentic proliferative IgA nephopathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrol. Dial. Transplant., 2003, 18, 1321-1329.
10. Nagy, J.; Miltenyi, M.; Dobos, M. and Burger, T. Tubular proteinuria in IgA glomerulonephritis. Clin. Nephrol., 1987, 27, 76-78.
11. Woo, K.T.; Lau, Y.K.; Lee, G.S.L.; Wei, S.S. and Lim, C.H. Pattern of proteinuria in IgA nephritis by SDS-PAGE: clinical significance. Clin. Nephrol., 1991, 36, 6-11.
12. th International Symposium on IgA Nephropathy, Saint-Etienne (France), March 26-27 th 2004, Abstract Book, page 79.
13. Bazzi, C.; Rizza, V.; Paparella, M.; Casellato, D.; Napodano, P.; Olivieri, G. and D'Amico, G. Fractional urinary excretion of IgG is the most powerful predictor of reno-protection by ACE-inhibitors in IgA Nephropathy. J. Nephrol., 2009, 22, 387-396.
14. Bazzi, C.; Rizza, V.; Raimondi, S.; Casellato, D.; Napodano, P. and D'Amico, G. In crescentic IgA nephropathy fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression. Clin. J. Am. Soc. Nephrol., 2009, 4, 929-935.
15. Abbate, M.; Zoia, C. and Remuzzi, G. How does proteinuria cause progressive renal damage? J. Am. Soc. Nephrol., 2006, 17, 2974-2984.
16. Barrat, J. and Topham, P. Urine proteomics: the present and future of measuring urinary protein components in disease. Can. Med. Assoc. J., 2007, 177, 361-368.
17. Julian, B.A.; Wittke, S.; Haubitz, M.; Zurbig, P.; Schiffer, E.; McGuire, B.M.; Wyatt, R.J. and Novak, J. Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases. World J. Urol., 2007, 25, 467-476.
18. Varghese, S.A.; Powell, T.B.; Budisavljevic, M.N.; Oates, J.C.; Raymond, J.R.; Almeida, J.S. and Arthur, J.M. Urine biomarkers predict the cause of glomerular disease. J. Am. Soc. Nephrol., 2007, 18, 913-922.
19. Fliser, D.; Novak, J.; Thongboonkerd, V.; Argiles, A.; Jankowski, V.; Girolami, M.A.; Jankowski, J. and Mischak, H. Advances in urinary proteome analysis and biomarker discovery. J. Am. Soc. Nephrol., 2007, 18, 1057-1071.
20. Thongboonkerd, V. Biomarker discovery in glomerular diseases using urinary proteomics. Proteomics Clin. Appl., 2008, 2, 1413-1421.
21. Haubitz, M.; Wittke, S.; Weissinger, E.M.; Walden, M.; Rupprecht, H.D.; Floege, J.; Haller, H. and Mischak, H. Urine protein pattern can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int., 2005, 67, 2313-2320.
22. Weissinger, E.M.; Wittke, S.; Kaiser, T.; Haller, H.; Bartel, S.; Krebs, R.; Golovko, I.; Rupprecht, H.D.; Haubitz, M.; Hecker, H.; Mischak, H. and Fliser, D. Proteome patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int., 2004, 65, 2426-2434.
23. Park, M.R.; Wang, E.H.; Jin, D.C.; Cha, J.H.; Lee, K.H.; Yang, C.W.; Kang, C.S. and Choi, Y.J. Establishement of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics, 2006, 6, 1066-1076.
24. Julian, B.A.; Wittke, S.; Novak, J.; Good, D.M.; Coon, J.J.; Kellmann, M.; Zurbig, P.; Schiffer, E.; Haubitz, M.; Modoveanu, Z.; Calcatera, S.M.; Wyatt, R.J.; Sykora, J.; Slalkova, E.; Mischak, H. and McGuire, B.M. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis, 2007, 28, 4469-4483.
25. Yokota, H.; Hiramoto, M.; Okada, H.; Kanno, Y.; Yuri, M.; Morita, S.; Naitou, M.; Ichikawa, A.; Katoh, M. and Suki, H. Absence of increased α,1-microglobulin in IgA nephropathy proteinuria. Mol. Cell. Proteomics, 2007, 6, 738-744.
26. Thongboonkerd, V.; Songtawee, N. and Sritippayawan, S. Urinary proteome profiling using microfluidic technology on a chip. J. Proteome Res., 2007, 6, 2011-2018.
27. Rocchetti, M.T.; Centra, M.; Papale, M.; Bortone, G.; Palermo, C.; Centonze, D.; Ranieri, E.; Di Paolo, S. and Gesualdo, L. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics, 2008, 8, 206-216.
28. Khositseth, S.; Kanitsap, N.; Warnnissorn, N. and Thongboonkerd, V. IgA nephropathy associated with Hodgkin's disease in children: a case repor, literature review and urinary proteome analysis. Pediatr. Nephrol., 2007, 22, 541-546.
29. Rossing, K.; Mischak, H.; Dakna, M.; Zurbig, P.; Novak, J.; Julian, B.A.; Good, D.M.; Coon, J.J.; Tarnow, L. and Rossing, P. Urinary Proteomics in Diabetes and CKD. J. Am. Soc. Nephrol., 2008, 19, 1283-1290.
30. Bazzi, C.; Petrini, C.; Rizza, V.; Arrigo, G.; Beltrame, A.; Pisano, L. and D'Amico, G. Urinary excretion of IgG andα1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am. J. Kidney Dis., 2001, 38, 240-248.
31. Bazzi, C.; Petrini, C.; Rizza, V.; Napodano, P.; Paparella, M.; Arrigo, G.; Pisano, L. and D'Amico, G. Fractional excretion of IgG predicts renal out come and response to therapy in primary focal segmental glomerulosclerosis: A pilot study. Am. J. Kidney Dis., 2003, 41, 328-335.
32. Philibert, D.; Cattran, D. and Cook, T. Clinicopathologic Correlation in IgA Nephropathy. Semin. Nephrol., 2008, 28, 10-17.
33. Tomino, Y. Editorial: Can urine polypeptide profiles be used to diagnose IgA nephropathy? Nat. Clin. Pract. Nephrol., 2005, 1, 72-73.